Related Experiment Videos
Dyslipoproteinemia in women. Special considerations
1George Washington University Medical Center, Lipid Research Center, Washington, DC.
Insights
Heart disease is a leading cause of death. Managing modifiable risk factors, including cholesterol and blood pressure, is crucial for women
Area of Science:
- Cardiovascular Medicine
- Endocrinology
- Women's Health
Background:
- Heart disease is the leading cause of death for both men and women.
- Key risk factors include high cholesterol, hypertension, diabetes, and smoking, many of which are modifiable.
- Women's lipoprotein profiles change throughout life due to hormonal influences like pregnancy, oral contraceptives, and menopause.
Purpose of the Study:
- To highlight the significant impact of hormonal changes on women's lipid profiles.
- To emphasize the role of endogenous and exogenous hormones in cardiovascular disease risk for women.
- To underscore the importance of individualized lipid management in women.
Main Methods:
- Review of existing literature on cardiovascular risk factors in women.
- Analysis of hormonal effects on lipoprotein profiles during different life stages.
- Discussion of therapeutic implications for managing dyslipidemia in women.
Main Results:
- Endogenous estrogen is associated with reduced heart disease risk in women.
- Estrogen replacement therapy at menopause may reduce risk, but effects depend on the type and dosage.
- Oral contraceptives can increase cardiovascular risk, particularly at higher doses, influencing lipid profiles.
Conclusions:
- Physicians must carefully assess women's baseline lipid profiles and monitor hormonal influences.
- Tailored management strategies are essential to achieve the least atherogenic lipid profile possible.
- Reducing cardiovascular risk factors, including lipids, is a critical physician responsibility for female patients.
Abstract:
Heart disease is the number one cause of death in women, as it is in men; risk factors include high cholesterol, high triglycerides, low HDL-C, diabetes, hypertension, and cigarette smoking. Most of these factors are alterable. The lipoprotein profile of a woman undergoes many changes during her lifetime because of the effects of endogenous hormones at pregnancy, the administration of oral contraceptives, and estrogen replacement at the menopause. Endogenous estrogen reduces the risk of heart disease in women as does unopposed estrogen replacement in the menopause. Oral contraceptives, on the other hand, can increase risk depending on the dose prescribed. Careful attention to a woman's native lipid profile, as well as to the impact of administered hormones on her lipids, is important. It is the responsibility of the physician to help patients achieve and maintain the least atherogenic lipid profile possible as well as to identify and reduce other cardiovascular risk factors.